Municipal Employees Retirement System of Michigan boosted its position in Hologic, Inc. (NASDAQ:HOLX) by 27.5% during the second quarter, Holdings Channel reports. The fund owned 24,810 shares of the medical equipment provider’s stock after buying an additional 5,350 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in Hologic were worth $1,126,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of HOLX. Cleararc Capital Inc. increased its stake in shares of Hologic by 1.1% in the first quarter. Cleararc Capital Inc. now owns 6,843 shares of the medical equipment provider’s stock worth $291,000 after buying an additional 77 shares during the last quarter. Compton Capital Management Inc. RI increased its stake in shares of Hologic by 0.6% in the first quarter. Compton Capital Management Inc. RI now owns 16,810 shares of the medical equipment provider’s stock worth $715,000 after buying an additional 100 shares during the last quarter. Advantus Capital Management Inc increased its stake in shares of Hologic by 0.4% in the first quarter. Advantus Capital Management Inc now owns 27,936 shares of the medical equipment provider’s stock worth $1,189,000 after buying an additional 116 shares during the last quarter. Shell Asset Management Co. increased its stake in shares of Hologic by 0.7% in the first quarter. Shell Asset Management Co. now owns 24,647 shares of the medical equipment provider’s stock worth $1,049,000 after buying an additional 182 shares during the last quarter. Finally, Curbstone Financial Management Corp increased its stake in shares of Hologic by 2.4% in the second quarter. Curbstone Financial Management Corp now owns 8,678 shares of the medical equipment provider’s stock worth $394,000 after buying an additional 200 shares during the last quarter. 94.46% of the stock is owned by institutional investors and hedge funds.

Shares of Hologic, Inc. (HOLX) opened at 38.33 on Thursday. The stock has a market capitalization of $10.75 billion, a PE ratio of 14.28 and a beta of 0.90. The company’s 50 day moving average is $44.21 and its 200-day moving average is $42.94. Hologic, Inc. has a 52 week low of $35.15 and a 52 week high of $46.80.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.01. The firm had revenue of $806.10 million during the quarter, compared to analyst estimates of $799.70 million. Hologic had a net margin of 25.65% and a return on equity of 23.18%. The business’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.51 earnings per share. On average, equities analysts predict that Hologic, Inc. will post $2.01 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/hologic-inc-holx-stake-raised-by-municipal-employees-retirement-system-of-michigan/1467078.html.

A number of equities research analysts have issued reports on the stock. Stifel Nicolaus upped their price objective on shares of Hologic from $45.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, May 11th. Jefferies Group LLC set a $49.00 price objective on shares of Hologic and gave the stock a “buy” rating in a research report on Sunday, May 28th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $51.00 price objective on shares of Hologic in a research report on Friday, July 14th. Barclays PLC reaffirmed an “equal weight” rating and issued a $51.00 price objective (down from $53.00) on shares of Hologic in a research report on Wednesday. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $45.00 price objective (down from $50.00) on shares of Hologic in a research report on Wednesday. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $48.64.

In related news, Director Lawrence M. Levy sold 9,193 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $42.93, for a total transaction of $394,655.49. Following the completion of the sale, the director now directly owns 46,206 shares in the company, valued at $1,983,623.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Lawrence M. Levy sold 9,076 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $42.80, for a total transaction of $388,452.80. Following the sale, the director now owns 43,165 shares of the company’s stock, valued at $1,847,462. The disclosure for this sale can be found here. Insiders have sold 60,627 shares of company stock valued at $2,632,911 over the last 90 days. 0.79% of the stock is currently owned by company insiders.

Hologic Company Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.